Drugs / G-CSF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01331590 | Jul 2011 → Oct 2014 | precursor lymphoblastic lymphoma/leukemia | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01331590 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Methionyl Human G-CSF” NCT01331590 ↗ |
| Route | Subcutaneous | “G-CSF = 10 mcg/kg/d SQ starting on day 1” NCT01331590 ↗ |